STOCK COMPARISON
IHH Healthcare Bhd vs HCA Healthcare: Fair Value & Quality
Both stocks run through our valuation models. Here is how IHH Healthcare Bhd (5225) and HCA Healthcare (HCA) compare, as of Aug 8, 2026.
As of Aug 8, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: IHH Healthcare Bhd trades at MYR 8.33 versus a fair value of MYR 4.61 (-45%), while HCA Healthcare trades at $409 versus $555 (+36%).
IHH Healthcare Bhd
5225.KLSE · MYR · Health Care
-45%
upside to fair value
overvalued
PriceMYR 8.33
Fair ValueMYR 4.61
Quality55/100
HCA Healthcare
HCA · USD · Health Care
+36%
upside to fair value
undervalued
Price$409
Fair Value$555
Quality62/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
IHH Healthcare BhdHCA Healthcare
Valuation
35.4×P/E (TTM)12.5×
0.71×P/S (TTM)1.06×
0.61×P/B—
4.6×EV/EBITDA7.8×
4.09×PEG1.18×
1.2%Dividend yield0.8%
MYR 0.11Dividend per share$2.94
Profitability
8%Net margin9%
15%Operating margin15%
8%Return on equity136%
4%Return on assets12%
Growth
4%Revenue growth (YoY)4%
12.7%Avg. growth/yr (3Y)7.9%
14.0%Avg. growth/yr (5Y)8.0%
Balance & size
0.26×Debt / equity—
$18BMarket cap$81B
healthyGrowth qualityhealthy
HCA Healthcare leads: 5 to 7 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
IHH Healthcare Bhdof which business quality 50 · market factors 63
HCA Healthcareof which business quality 66 · market factors 45
ProfitabilityMargins and returns on capital today
32
76
Quality GrowthAre margins and returns improving?
27
61
CashflowEarnings quality: real cash, not paper profit
52
62
Fin. StrengthBalance sheet, leverage, solvency risk
55
39
InvestmentDisciplined investing over empire-building
61
75
Low VolatilityCalm price path (market factor)
95
59
MomentumPrice trend over the last 3–12 months (market factor)
46
38
52W MomentumDistance to the 52-week high (market factor)
56
43
Net IssuanceBuybacks instead of dilution
80
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
IHH Healthcare Bhd
DCF ModelsMYR 4.79
Earnings-BasedMYR 3.10
Dividend DiscountMYR 1.85
MultiplesMYR 4.48
Asset-BasedMYR 2.30
Growth DCFMYR 4.30
Economic ProfitMYR 2.70
Growth EarningsMYR 4.63
26 of 26 models see the stock below the current price.
HCA Healthcare
DCF Models$519
Earnings-Based$289
Dividend Discount$53.85
Multiples$612
Growth DCF$540
Economic Profit$419
Growth Earnings$478
6 of 23 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
IHH Healthcare Bhd
Bear MYR 2.88Fair Value MYR 4.61Bull MYR 6.21
MYR 8.33 = current price (white tick)
HCA Healthcare
Bear $270Fair Value $555Bull $841
$409 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
IHH Healthcare Bhd · Health Care
Quality score55 · above median
Fair value upside-45% · below median
HCA Healthcare · Health Care
Quality score62 · Top 25%
Fair value upside+36% · Top 25%
Bottom line
As of Aug 8, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: IHH Healthcare Bhd trades at MYR 8.33 versus a fair value of MYR 4.61 (-45%), while HCA Healthcare trades at $409 versus $555 (+36%).
HCA Healthcare has the higher quality score (62/100).
See the full analysis →
More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Free · Top-25 report
See the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
